Knight Therapeutics | Des Atouts



Assets Changement Date
Acasti Pharma USD 61.22M 4.12M 2024-12
Alaunos Therapeutics USD 3.55M 1.13M 2024-09
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Avita Medical AUD 79.71M 8.12M 2024-12
Canopy Growth CAD 1.16B 68.13M 2024-12
Cronos Group USD 1.17B 17.82M 2024-12
Dianthus Therapeutics USD 354.25M 14.71M 2024-09
Ionis Pharmaceuticals USD 3B 77.42M 2024-12
IQVIA Holdings USD 26.9B 281M 2024-12
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Moderna USD 14.14B 1.66B 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Organon & Co USD 12.75B 598M 2024-09
Revvity USD 12.39B 377.26M 2024-12
Tectonic Therapeutic USD 168.72M 25.19M 2024-09
Tilray USD 4.19B 70.11M 2024-11
Viatris USD 41.5B 3.25B 2024-12
Xeris Pharmaceuticals USD 323.06M 1.96M 2024-12



Knight Therapeutics Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.